Analysis relationships between pharmacokinetic parameters in silico/in vivo of selected antiviral drugs based on structural analysis

Advances in Clinical and Experimental Medicine

Volumn 17, Issue 3, 2008, Pages 285-292

  Grabowski, Tomasz ^a   Gumułka, Stanisław W ^b   Borucka, Beata ^a   Raszewski, Wiesław ^a  

^a Center of Pharmacokinetics Research FILAB   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Bioavailability; CLogP; Pharmacokinetics; PSA; Rimantadine

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; CARBOXYOSELTAMIVIR; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ANIMAL CELL; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHILICITY; IN VIVO STUDY; INFLUENZA; LIPOPHILICITY; NONHUMAN; PHYSICAL CHEMISTRY; PREDICTION; STRUCTURE ANALYSIS;

EID: 48049112066     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Machatha SG, Yalkowsky SH: Comparison of the octanol/water partition coefficients calculated by CLogP, ACDLogP and KowWin to experimentally determined values. Int J Pharm 2005, 294, 185-92.
2. Ertl P, Rohde B, Selzer P: Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J Med Chem 2000, 5, 3714-3717.
3. Ertl P, Muhlbacher J, Rohde B, Selzer P: Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis. SAR QSAR Environ Res 2003, 14, 321-328.
4. Ertl P: Cheminformatics analysis of organic substituents: identification of the most common substituents, calculation of substituent properties, and automatic identification of drug-like bioisosteric groups. J Chem Inf Comput Sci 2003, 43, 374-380.
5. Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL: Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm 2004, 12, 85-96.
6. Broto P, Moreau G, VanDycke C: Molecular structures: perception, autocorrelation descriptor and QSAR studies. System of atomic contributions for the calculation of the n-octanol/water coefficients. Eur J Med Chem 1984, 19, 71-78.
7. Balaz S, Lukacova V: Subcellular pharmacokinetics and its potential for library focusing. J Mol Graph Model 2002, 20, 479-490.
8. Clark DE: Prediction of intestinal absorption and blood brain barrier penetration by computational methods. Comb Chem High Throughput Screen 2001, 4, 477-496.
9. Pedretti A, Villa L, Vistoli G: Vega A Versatile Program To Convert, Handle And Visualize Molecular Structure on Windows-Based Pcs. J Mol Graph 2002, 21, 47-49.
10. Pedretti A, Villa L, Vistoli G: Vega - An Open Platform To Develop Chemo-Bio-Informatics Applications, Using Plug-In Architecture And Script Programming. J Comput Aided Mol Des 2004, 18, 167-173.
11. Balaban AT: Highly discriminating distance-based topological index. Chem Phys Lett 1982, 89, 399-404.
12. Balaban AT: Topological indices based on topological distances in molecular graphs. Pure Appl Chem 1983, 55, 199-206.
13. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 1997, 23, 3-25.
14. Lipinski CA: Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000, 44, 235-249.
15. Lipinski CA: Single-Mode compound retrieval for QSAR, QSPR data sets, and batch mode exact structure searching. J Pharm Sci 2002, 91, 2470-2472.
16. Hayden FG, Minocha A, Spyker DA, Hoffman HE: Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrob Agents Chemother 1985, 28, 216-221.
17. Anonymous: Review on influenza antiviral medicinal products for potential use during pandemic. EMEA 2005, 1-18.
18. Wills RJ, Choma N, Buonpane G, Lin A, Keigher N: Relative bioavailability of rimantadine HCl tablet and syrup formulations in healthy subjects. J Pharm Sci 1987, 76(12), 886-888.